Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 1
2(50.0%)
N/A
1(25.0%)
Phase 2
1(25.0%)
4Total
Phase 1(2)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04300751Phase 1Completed

The Behavioral Effects of Opioids and Alcohol

Role: lead

NCT04315181Phase 1Completed

Prescription Medication Interactions

Role: lead

NCT00999544Not ApplicableCompleted

Aprepitant Effects on Oxycodone Response

Role: lead

NCT00617201Phase 2Completed

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

Role: lead

All 4 trials loaded